Get Surfshark VPN at https://Surfshark.deals/thoughty2 and enter promo code THOUGHTY2 for 83% off and 4 extra months for free!
Get my new book Bread and Circuses: https://bit.ly/breadandcircusesbook.
Listen to my new podcast Random Interesting Facts: http://bit.ly/RIFThoughty2
Or watch it on YouTube: http://bit.ly/RIFPodcastYT
Thoughty2 Audiobook: https://geni.us/t2audio.
When we think about gene editing, the first thing we remember is the designer babies, and that it’s usually called unethical. But actually, gene editing (CRISPR) may be one of the most promising upcoming medical technologies. Learn why in this video.
Check out other videos from this series:
https://www.youtube.com/playlist?list=PLnWSi4zEceYXPCBYXZ9ZEV-9q44ebksoo.
0:00 — Opening scene.
0:20 — Gene editing is promising. Here’s why.
2:35 — Also, it can transform the beauty industry.
3:49 — How does gene editing work?
4:16 — My thoughts on that.
5:16 — End credits.
Text me: [email protected].
Europe will soon produce a strategically vital component in the modern global economy as US semiconductor giant Intel chooses the site for a new cutting-edge chip factory.
Recent problems in global supply chains have highlighted the fundamental importance of semiconductors, which are used in a growing number of products including cars, TVs and smartphones.
Keen demand and the closure of semiconductor plants, particularly in Asia, due to pandemic disruptions led to a global chip shortage and forced car manufacturers such as Ford, Nissan and Volkswagen to scale back production.
All 18 COVID-19 patients hospitalized with moderate or severe symptoms who were administered the drug Amor-18 developed by Israeli biotech company Amorphical in a phase II clinical trial recovered and were discharged in a few days, the company announced Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.
All 18 hospitalized individuals administered the treatment developed by Israeli biotech company Amorphical in a phase II trial recovered and were discharged in a few days.
When three is not enough.
Israel has announced a fourth dose of the COVID-19 vaccine to people older than 16. The additional dose will be given to senior citizens, medical workers, people with suppressed immune system.
#Israel #COVID #ImmuneSystem.
Companies and labs are racing to build next-generation devices that track and translate brain activity to help people immobilized by disease or injury handle tasks requiring movement.
Artificial intelligence (AI) backed drug discovery company Insilico Medicine announced last week that it was dosing the first healthy volunteer in a microdose trial of ISM 001–005. Designed with the help of AI, the drug is a small-molecule inhibitor of a biological target that was discovered by Pharma. AI. The trial is being conducted in Australia.
The AI-designed drug will be used to treat chronic lung disease idiopathic pulmonary fibrosis, or IPF usually leads to progressive and irreversible lung-function decline and affects 20 people out of over 100,000 globally.
Chief Scientific Officer of Insilico, Freng Ren, said in a press release that this drug discovery and trial marks a significant milestone in the AI-drug discovery space. This is because the said candidate is the first-ever AI-discovered novel molecule based on an AI-discovered target.
Targeting cancers and viruses, better knowledge of the human immune system is leading to new medicines.
Researchers have discovered that using a thin-film coating of copper or copper compounds on surfaces could enhance copper’s ability to inactivate or destroy the SARS-CoV-2 virus responsible for COVID-19.
In a study that began soon after the pandemic hit in March 2020, University of Waterloo engineering graduate students investigated how six different thin metal and oxide coatings interacted with HCov-229E, a coronavirus that is genetically like SARS-CoV-2 but safer to work with.
“While there was already some data out there on the lifetime of the virus on common-touch surfaces like stainless steel, plastics and copper, the lifetime of the virus on engineered coatings was less understood,” said Kevin Mussleman, the Waterloo mechanical and mechatronics engineering professor who led the study.
Circa 2017
A new interface system allowed three paralyzed individuals to type words up to four times faster than the speed that had been demonstrated in earlier studies.
